Clinical Drug Experience Knowledgebase

Multiple Myeloma

Acne Vulgaris (Phase 2)

Amyloidosis (Phase 3)

Anemia (Phase 2)

Anemia, Aplastic (Phase 2)

Anemia, Diamond-Blackfan (Phase 2)

Anemia, Refractory (Phase 2)

Antigens, CD20 (Phase 1)

Antiphospholipid Syndrome (Phase 1)

Arthritis, Rheumatoid (Phase 1)

Autoimmune Diseases (Phase 2)

Autoimmune Diseases of the Nervous System (Phase 2)

beta-Thalassemia (Phase 1/Phase 2)

Bone Marrow Cells (Phase 2)

Bone Marrow Failure Disorders (Phase 2)

Brain Neoplasms (Phase 3)

Breast Neoplasms (Phase 3)

Breast Neoplasms, Male (Phase 2)

Bronchopulmonary Dysplasia (Phase 1)

Burkitt Lymphoma (Phase 3)

Carcinoma (Phase 2)

Cardiomyopathies (Phase 1/Phase 2)

Cartilage Diseases (Phase 2)

Central Nervous System Neoplasms (Phase 3)

Cerebellar Diseases (Phase 2)

Cerebral Palsy (Phase 2)

Chordoma (Phase 1)

Chromosome Aberrations (Phase 2)

Chronic Disease (Phase 2)

Colonic Neoplasms (Phase 1)

Colorectal Neoplasms (Phase 1/Phase 2)

Coronary Artery Bypass (Phase 1/Phase 2)

Crohn Disease (Phase 2)

Diabetes Mellitus, Type 1 (Phase 2)

Diffuse Intrinsic Pontine Glioma (Phase 1)

Diploidy (Phase 2)

Drug-Related Side Effects and Adverse Reactions (Phase 2)

Encephalitis (Phase 2)

Endocrine System Diseases (Phase 1/Phase 2)

Fallopian Tube Neoplasms (Phase 2)

Fanconi Anemia (Phase 2)

Glioblastoma (Phase 2/Phase 3)

Glioma (Phase 1)

Gliosarcoma (Phase 1/Phase 2)

Glucose Metabolism Disorders (Phase 1/Phase 2)

Graft vs Host Disease (Phase 3)

Hamartoma (Phase 2)

Head and Neck Neoplasms (Phase 2)

Hematologic Diseases (Phase 2)

Hematopoietic Stem Cell Transplantation (Phase 2)

Hemoglobinuria, Paroxysmal (Phase 2)

HIV Infections (Phase 2)

Hodgkin Disease (Phase 3)

Immune System Diseases (Phase 1/Phase 2)

Infections (Phase 2)

Infertility, Male (Phase 1/Phase 2)

Inflammatory Breast Neoplasms (Phase 2)

Intestinal Neoplasms (Phase 2)

Intraocular Lymphoma (Phase 2)

Kidney Neoplasms (Phase 2)

Lambert-Eaton Myasthenic Syndrome (Phase 2)

Leukemia (Phase 3)

Leukemia, Biphenotypic, Acute (Phase 2)

Leukemia, Eosinophilic, Acute (Phase 3)

Leukemia, Hairy Cell (Phase 2)

Leukemia, Large Granular Lymphocytic (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)

Leukemia, Lymphoid (Phase 2/Phase 3)

Leukemia-Lymphoma, Adult T-Cell (Phase 2)

Leukemia, Mast-Cell (Phase 2)

Leukemia, Monocytic, Acute (Phase 3)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 3)

Leukemia, Myeloid (Phase 3)

Leukemia, Myeloid, Acute (Phase 4)

Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (Phase 2)

Leukemia, Myeloid, Chronic-Phase (Phase 2)

Leukemia, Myelomonocytic, Acute (Phase 3)

Leukemia, Myelomonocytic, Chronic (Phase 2)

Leukemia, Myelomonocytic, Juvenile (Phase 2)

Leukemia, Neutrophilic, Chronic (Phase 2)

Leukemia, Plasma Cell (Phase 2)

Leukemia, Prolymphocytic (Phase 3)

Leukemia, Prolymphocytic, B-Cell (Phase 2)

Leukemia, Prolymphocytic, T-Cell (Phase 3)

Liver Neoplasms (Phase 1)

Lung Neoplasms (Phase 3)

Lupus Erythematosus, Systemic (Phase 2/Phase 3)

Lymphoma (Phase 3)

Lymphoma, AIDS-Related (Phase 1)

Lymphoma, B-Cell (Phase 2)

Lymphoma, B-Cell, Marginal Zone (Phase 2)

Lymphoma, Follicular (Phase 3)

Lymphoma, Large B-Cell, Diffuse (Phase 3)

Lymphoma, Large-Cell, Anaplastic (Phase 2)

Lymphoma, Large-Cell, Immunoblastic (Phase 3)

Lymphoma, Mantle-Cell (Phase 3)

Lymphoma, Non-Hodgkin (Phase 3)

Lymphoma, Primary Cutaneous Anaplastic Large Cell (Phase 2)

Lymphoma, T-Cell (Phase 2)

Lymphoma, T-Cell, Peripheral (Phase 2)

Lymphomatoid Granulomatosis (Phase 2)

Lymphoproliferative Disorders (Phase 2)

Mastocytosis (Phase 2)

Mediastinal Neoplasms (Phase 3)

Medulloblastoma (Phase 3)

Melanoma (Phase 2)

Meningitis (Phase 1/Phase 2)

Metabolic Diseases (Phase 1/Phase 2)

Multiple Myeloma (Phase 3)

Multiple Sclerosis (Phase 2)

Multiple Sclerosis, Relapsing-Remitting (Phase 2)

Myasthenia Gravis (Phase 2)

Myelodysplastic-Myeloproliferative Diseases (Phase 3)

Myelodysplastic Syndromes (Phase 4)

Myeloproliferative Disorders (Phase 3)

Myocardial Infarction (Phase 2/Phase 3)

Neoplasm Metastasis (Phase 2/Phase 3)

Neoplasm, Residual (Phase 2)

Neoplasms (Phase 3)

Neuroblastoma (Phase 3)

Neuroectodermal Tumors (Phase 3)

Neuromyelitis Optica (Phase 2)

Neutropenia (Phase 3)

Opsoclonus-Myoclonus Syndrome (Phase 2)

Organ Transplantation (Phase 2)

Osteoarthritis, Hip (Phase 1)

Osteoarthritis, Knee (Phase 1)

Ovarian Neoplasms (Phase 3)

Pancreatic Neoplasms (Phase 1/Phase 2)

Pemphigus (Phase 1)

Peripheral Vascular Diseases (Phase 1)

Plasmablastic Lymphoma (Phase 1/Phase 2)

Plasmacytoma (Phase 2)

Polycythemia Vera (Phase 2)

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (Phase 2)

Precancerous Conditions (Phase 2)

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Phase 3)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 3)

Primary Myelofibrosis (Phase 3)

Prognosis (Phase 2)

Prostatic Neoplasms (Phase 2)

Retinitis Pigmentosa (Phase 1/Phase 2)

Retinoblastoma (Phase 3)

Rhabdoid Tumor (Phase 3)

Rhabdomyosarcoma (Phase 2)

Sarcoidosis (Phase 1/Phase 2)

Sarcoma (Phase 3)

Sarcoma, Ewing (Phase 2)

Sarcoma, Myeloid (Phase 2)

Scleroderma, Systemic (Phase 2)

Severe Combined Immunodeficiency (Phase 2)

Sezary Syndrome (Phase 2)

Shwachman-Diamond Syndrome (Phase 2)

Smoldering Multiple Myeloma (Phase 1/Phase 2)

Spinal Cord Injuries (Phase 1/Phase 2)

Stem Cell Transplantation (Phase 2)

Stiff-Person Syndrome (Phase 2)

Stroke (Phase 1)

Teratoma (Phase 2)

Testicular Neoplasms (Phase 3)

Thrombocythemia, Essential (Phase 2)

Thrombocytopenia (Phase 2)

Tissue Donors (Phase 2)

Translocation, Genetic (Phase 2)

Transplantation (Phase 2)

Transplantation, Autologous (Phase 2)

Transplantation, Homologous (Phase 2)

Urinary Bladder Neoplasms (Phase 2)

Uterine Cervical Neoplasms (Phase 2)

Vaginal Neoplasms (Phase 2)

Vasculitis, Central Nervous System (Phase 2)

Waldenstrom Macroglobulinemia (Phase 3)

Wiskott-Aldrich Syndrome (Phase 2)